Joshi Mehul
Known title: Chief Financial Officer & PAOCIK: 0001939602
Associated companies
Transaction History
| LUNG | ▼ Sell | Open Market | 4,271 | $7K | 9/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 3,665 | $6K | 9/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 3,721 | $12K | 6/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 4,340 | $14K | 6/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 14,384 | $102K | 3/3/2025 | View on chart |
| LUNG | ▲ Buy | Grant | 108,000 | $0 | 3/3/2025 | View on chart |
| LUNG | ▲ Buy | Grant | 125,870 | $0 | 5/6/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27
Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.